HEALWELL AI INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.72 USD | +0.29% |
|
-16.50% | +213.24% |
| 06-26 | Healwell AI Backs Musk-founded X.AI With US$2 Million Investment | MT |
| 06-26 | X.AI Corp. announced that it has received $2 million in funding from Healwell AI Inc. | CI |
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- For the past twelve months, EPS forecast has been revised upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +213.24% | 226M | - | - | |
| -32.30% | 13.37B | B+ | ||
| +3.98% | 11.75B | B+ | ||
| -3.60% | 11.57B | B | ||
| +7.59% | 10.85B | B+ | ||
| +26.78% | 8.55B | B | ||
| -11.61% | 7.24B | A- | ||
| +7.53% | 6.84B | B- | ||
| +8.77% | 6.5B | D | ||
| 0.00% | 4.4B | - | - |
Investor Rating
-
Trading Rating
-
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-
Valuation
P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
-
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- AIDX Stock
- HWAI.F Stock
- Ratings Healwell AI Inc.
